10-Year checkup for hip replacement device
NCT ID NCT02846636
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 people who received a total hip replacement with the Mpact cup to see how well the implant holds up over 10 years. Researchers will measure implant survival, hip function, and any complications. The goal is to understand the long-term performance and safety of this device.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mpact cup (hip implant device)
- What this could lead to
- If successful, this study could confirm that the Mpact cup is a reliable, long-lasting option for hip replacement patients.
- What could go wrong
- This is an observational study with no control group, so results may not prove the cup is better than other implants. The study is also currently suspended, which may affect completion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Aug 2014
- Expected to finish
-
Apr 2029
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients eligible for total hip arthroplasty who meet the inclusion criteria will be invited in the study
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients requiring a total hip replacement who meets the standard indications for use for Medacta implants * patients who accept to participate in the study * patients who signed the consent form for the treatment of personal data Exclusion Criteria: * patients presenting conditions identified as contraindication for Medacta implants * revision surgeries
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Total hip replacement are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Clinique Médico-Chirurgicale Paris V
Paris, France, 75007, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI chat coach may spot complications after joint replacement surgery
- Can unstable surfaces rebuild balance after hip replacement?
- Can disposable surgical tools make hip replacement cheaper and safer?
- Can a nerve pain drug cut opioid use after hip surgery?
- New study to uncover best wound care after joint replacement
- Sound therapy may soothe post-surgery pain and worry